Upload
olief-shoppers
View
214
Download
0
Embed Size (px)
Citation preview
7/29/2019 541-546
1/6
2011 Wichtig Editore - ISSN 1120-6721
Eur J Ophthalmol ( 2012 ; :4) 541-54622
541
INTRODUCTION
Postoperative endophthalmitis is one of the most serious
complications of cataract surgery and may lead to severe
visual loss. The prevalence of postoperative endophthal-
mitis following cataract surgery is 0.06% to 0.68% (1).
A meta-analysis by Taban et al showed a significant in-
crease in postoperative endophthalmitis from 0.087% in
the 1990s to 0.265% for the 2000-2003 period (2). This up-
ward trend in the prevalence of postoperative endophthal-
Application of 10% povidone iodine reduces
conjunctival bacterial contamination rate in patientsundergoing cataract surgery
Martin M. Nentwich1, Mohammed Rajab1, Christopher N. Ta2, Lisa He2, Martin Grueterich1,
Christos Haritoglou1, Arnd Gandorfer1, Anselm Kampik1, Herminia Mino De Kaspar1,2
1Department of Ophthalmology, Ludwig-Maximilians-University, Munich - Germany2Department of Ophthalmology, School of Medicine, Stanford University, Stanford, California - USAD ep artmen tofO ph tha lmo logy ,Lu d wig -Max imilia ns-U niv ersit y ,Munic h-G e rma ny D ep artmen tofO ph tha lmo logy ,Sc hoo lofMe d icin e,S tan ford U n iv ers ity ,S tan ford ,C alifo rnia -U SAD ep artmen tofO ph tha lmo logy ,Lu d wig -Max imilia ns-U niv ersit y ,Munic h-G e rma ny D ep artmen tofO ph tha lmo logy ,Lu d wig -Max imilia ns-U niv ersit y ,Munic h-G e rma ny D ep artmen tofO ph tha lmo logy ,Lu d wig -Max imilia ns-U niv ersit y ,Munic h-G e rma ny D ep artmen tofO ph tha lmo logy ,Lu d wig -Max imilia ns-U niv ersit y ,Munic h-G e rma ny ;D ep artmen tofO ph tha lmo logy ,Sc hoo lofMe d icin e,S tan ford U n iv ers ity ,S ta nford ,C alifo rnia -U SAD ep artmen tofO ph tha lmo logy ,Lu d wig -Max imilia ns-U niv ersit y ,Munic h-G e rma ny
PURPOSE. To determine the efficacy of 10% povidone iodine (PVI) drops given before cataract extrac-
tion in addition to routine irrigation of the conjunctival sac with 1% PVI.
METHODS. This prospective, randomized, single-center study at the Department of Ophthalmology,
Ludwig-Maximilians-University, Munich, includes 263 eyes of 242 patients undergoing cataract sur-
gery. Patients were randomized to receive 3 drops of 10% PVI into the conjunctival sac (study group)
or no PVI drops (control group). All patients underwent periorbital disinfection with 10% PVI followed
by irrigation of the conjunctiva with 10 mL of 1% PVI. Specimens were obtained prior to the applica-
tion of PVI, after antibiotic administration (T1), after irrigation with PVI but before surgery (T2), and at
the conclusion of surgery (T3).
RESULTS. After PVI disinfection, the number of positive cultures was significantly reduced in all groups
(p
7/29/2019 541-546
2/6
2011 Wichtig Editore - ISSN 1120-6721542
10% Povidone iodine as prophylaxis before cataract surgery
stratified to outpatient and inpatient groups. All 112 eyes of
outpatients received one drop of topical neomycin (Alcon
Pharma, Freiburg, Germany) the hour prior to surgery while
151 eyes of inpatients received one drop of topical neomycin
4 times daily on the day prior to surgery and one drop in the
morning on the day of surgery. If surgery was scheduled in
the afternoon, the patients received a second drop of topicalneomycin before being transferred to the operating room.
Patients were randomized to the control and study groups.
In the preoperative area, the patients in the study group
received 3 drops of 10% PVI (Braunol; B. Braun, Melsun-
gen, Germany) in the conjunctival sac (in a single applica-
tion) while the control group received none. Afterwards,
all patients of both groups underwent standard periorbital
disinfection using 10% PVI scrub on the eyelids and sur-
rounding skin followed by application of gauze soaked
with 10% PVI on the closed lids for 5 minutes. After the
patient had been transferred into the operating room, theconjunctival sac was vigorously irrigated with 10 mL of
1% povidone iodine solution in both groups. Next, the
brow, upper and lower eyelids, eyelashes, and the adja-
cent forehead, nose, cheeks, and temporal orbital area
were again scrubbed with 10% PVI just prior to surgery.
The incubation time was identical in both groups to avoid
any confounding factor in this respect. Figure 1 summa-
rizes the infection prophylaxis regimen.
Conjunctival specimens from the surgery eyes were ob-
tained at the following time points: T1, prior to the application
of PVI but after the administration of topical neomycin antibi-
Povidone-iodine (PVI) antisepsis has proven to reduce
the risk of endophthalmitis following cataract surgery (6).
Due to the low prevalence of these cases, a prospective
randomized study evaluating the efficacy of any prophy-
lactic measure to reduce the actual risk of postoperative
endophthalmitis would require a very large number of pa-
tients and is impractical to perfom.In the current study, we compare 2 different methods of
preoperative application of PVI. The goal of this study was
to determine whether 10% PVI drops applied to the con-
junctival sac followed by irrigation of the conjunctival sac
with 1% PVI is superior in reducing conjunctival bacterial
contamination rate compared to 1% PVI irrigation alone.
MATERIALS AND METHODS
Consecutive patients undergoing cataract surgery were en-rolled in this prospective study. All surgeries were performed
at the Department of Ophthalmology, Ludwig-Maximilians-
University Munich from July to December 2008. The study
was approved by the Institutional Review Board of Ludwig-
Maximilians-University, Munich. Informed consent was ob-
tained from all patients prior to enrollment in the study.
In Germany, patients with significant medical illness such as
severe hypertension, poorly controlled diabetes mellitus, or
a history of stroke or myocardial infarction may be admitted
to hospital the day prior to cataract surgery. Because of the
difference in preoperative antibiotics regimen, patients were
Fig. 1 - Outline of the infection prophylaxis regimen. The individual steps in the preoperative infection prophylaxis regimen are illustrated. The
difference between the control and the study groups is shown in light gray. PVI = povidone iodine.
7/29/2019 541-546
3/6
2011 Wichtig Editore - ISSN 1120-6721 543
Nentwich et al
lowing the application of PVI. For the outpatient group, there
was no difference at baseline (T1) cultures between the con-
trol group and the study group (p=0.25). There was a trend
in fewer positive cultures for the study group (17%) com-
pared to the control group (29%) following the application of
PVI (T2), but this was not statistically significant (p=0.1). At
the conclusion of surgery (T3), the study group had signifi-
cantly fewer positive cultures compared to the control group
(p=0.03); specifically, a fourfold difference (4% versus 16%).
For the inpatient group, the study group had a higher initial(T1) positive culture result compared to the control group,
86% versus 69%, respectively (p=0.01). However, following
the application of PVI, the study group had a significantly
lower positive culture rate compared to the control group
(12% versus 28%) (p=0.01). The patients in the study group
continue to have a lower culture-positive rate at the conclu-
sion of surgery, 1% versus 10% (p=0.03). Table I and Fig-
ures 2 and 3 summarize the results. Table II shows the p
value comparing different patient groups.
Bacteria isolated from the conjunctiva prior to PVI applica-
tion, in decreasing frequency, were coagulase-negative
otics; T2, following all the different applications of PVI, just pri-
or to surgery; T3, at the conclusion of surgery. All specimens
were obtained by the surgeon in masked fashion. The speci-
mens were inoculated and incubated in thioglycolate broth at
37C for 5 days. The microbiologist who interpreted the cul-
ture results was masked with regard to the patient group. In
all positive cultures, bacteria were isolated (first on blood agar
[Columbia agar with 5% sheep blood], MacConkey agar, and
on agar chromID-CPS3 agar), identified and tested for antibi-
otic susceptibility with Vitek2 Compact System (all materialswere obtained from bioMerieux, Marcy lEtoile, France), and
the results compared between the groups. Cross tab analysis
using chi-square test (SPSS for Windows, SPSS Inc., Chi-
cago, Illinois, USA) was performed to determine statistically
significant differences between the groups.
RESULTS
In all patients, there was significant reduction (p
7/29/2019 541-546
4/6
2011 Wichtig Editore - ISSN 1120-6721544
10% Povidone iodine as prophylaxis before cataract surgery
endophthalmitis. Table III demonstrates the distribution of
bacteria in the 2 patient groups at the different timepoints.
There was no obvious intraoperative and postoperative
toxicity from PVI, but the current study was not designed
to assess toxicity of PVI.
Staphylococcus 101/147 (68.7%), followed by Propioni-
bacterium acnes 26/147 (17.7%), -hemolytic Streptococ-
cus 7/147 (4.8%), Staphylococcus aureus 6/147 (4.1%),
Enterococcus faecalis 4/147 (2.6%), Micrococcus sp
1/147 (0.7%), -hemolytic Streptococcus 1/147 (0.7%),
andAerococcus urinae 1/147 (0.7%). There was no case of
TABLE II - p VALUES (CHI-SQUARE TEST)
Outpatients Inpatients
Control group Study group Control group Study group
T1 vs T2
7/29/2019 541-546
5/6
2011 Wichtig Editore - ISSN 1120-6721 545
Nentwich et al
Despite all efforts to minimize the preoperative conjunctival
bacterial load, surgical instruments and aspirates of aque-
ous humor continue to show bacterial contamination. Ten
out of 39 (26%) microsurgical knives used for paracentesis
in cataract surgery were contaminated, while needles used
in strabismus surgery were contaminated in 15.1% and
19% according to 2 other studies (17-19).
A previously published study on 39 patients showed no differ-
ence between preoperative periorbital disinfection with 10%
PVI for 5 minutes and 5% PVI for 1 minute (10). In contrast,
our study suggest that the topical application of 3 additional
drops of 10% PVI directly into the conjunctival sac results in
a statistically significant greater reduction in the conjunctival
contamination rate than irrigation with 1% PVI alone.
The baseline cultures (T1) were similar between the control
group and the study group for the outpatient group but dif-
ferent for the inpatient group. The reason for this difference is
unclear as patients were randomized to the control and study
groups. We found no difference in the dosing of preoperative
antibiotics between the control and study groups (data not
shown). Despite an initially higher positive culture rate for the
study group at T1, the additional drops of 10% PVI resulted in
a greater reduction of conjunctival bacterial flora at T2 and T3,
as demonstrated by a significantly lower positive culture rate
for the study group compared to the control group.There are several limitations to our study. First of all, this
study provides only qualitative data (percentage of posi-
tive cultures), and therefore, no conclusions on the number
of colony-forming units can be drawn. Second, conjunctival
cultures were not obtained prior to the administration of anti-
biotics. However, since patients were randomized, we would
not expect a difference in the patient population between
the control and study group. Finally, as with many published
studies, ours focused on the conjunctival bacterial flora as a
surrogate marker for the risk for endophthalmitis. No studies
have proven a correlation between conjunctival contamina-tion and endophthalmitis and therefore, we cannot conclude
from our results regarding the actual risk of endophthalmitis.
Despite the limitations of our study, our results suggest
that additional drops of 10% PVI to the conjunctival sac
reduced the conjunctival contamination rate in patients un-
dergoing cataract surgery. This reduction is in addition to
the known efficacy of 10% PVI periorbital scrub and 1%
PVI irrigation of the conjunctiva. Further studies could be
considered to quantify the effects of 10% PVI drops on the
conjunctival bacterial flora relative to the risk of postopera-
tive endophthalmitis.
DISCUSSION
We performed this study in order to evaluate whether the
additional application of 3 drops of 10% PVI directly into
the conjunctival sac would reduce the conjunctival bacte-
rial contamination rate to a greater extent than the scrub-
bing of the eyelids and periorbital area with 10% PVI and
irrigation with 1% PVI. Our study of 263 eyes demonstrat-
ed that the addition of 3 drops of 10% PVI to the conjunc-
tival sac further reduced the rate of conjunctival cultures in
the perioperative period compared to 10% PVI periorbital
scrub and 1% PVI irrigation of the conjunctiva. This reduc-
tion was statistically significant at the conclusion of surgery
for the outpatient group. For the inpatient group, the study
group had significantly lower conjunctiva culture rate than
the control group following the application of PVI just prior
to surgery and at the conclusion of surgery. The incubation
time of PVI was identical in both groups to avoid any con-
founding factor in this respect. The safety of 10% PVI used
in the periorbital area has been described previously as
well as the use of 5% PVI on the ocular surface itself (7-12).
The bacteria identified at T1, which is after preoperative
antibiotic prophylaxis and before PVI disinfection, were
part of the normal conjunctival flora and similar to previ-
ously published studies of patients undergoing ocular sur-gery (13, 14). It is thought that the major source of post-
operative infections is the bacteria from the conjunctival
and eyelid flora of patients undergoing intraocular surgery.
Therefore, the preoperative reduction of the conjunctival
bacterial load may reduce the risk of postoperative endo-
phthalmitis. Povidone-iodine has been shown to be an ef-
fective and well-tolerated antiseptic in ophthalmic surgery
(7, 15). Apt et al demonstrated a reduction in numbers of
colonies by 91% and a decrease in the number of species
of 50% following the application of one drop 5% PVI in the
cul-de-sac (15). In a prospective study, Mio de Kaspar etal showed that irrigation of the fornices with 5% povidone-
iodine was associated with significantly fewer positive
conjunctival cultures at the time of surgery compared with
the application of 2 drops on the conjunctiva. This sug-
gests that irrigation of the conjunctival sac may be supe-
rior in reducing the conjunctival bacterial load (11). While
prospective studies have shown that topical antibiotics
in combination with PVI significantly reduce conjunctival
bacterial load, no study has been able to demonstrate that
the additional application of topical antibiotics reduces the
risk of postoperative endophthalmitis (16).
7/29/2019 541-546
6/6
2011 Wichtig Editore - ISSN 1120-6721546
10% Povidone iodine as prophylaxis before cataract surgery
comparative evaluation of povidone-iodine (10% for 5 min-
utes versus 5% for 1 minute) as prophylaxis for ophthalmic
surgery. J Cataract Refract Surg 2008; 34: 171-2.
11. Mio de Kaspar H, Chang RT, Singh K, Egbert PR, Blumen-
kranz MS, Ta CN. Prospective randomized comparison of
2 different methods of 5% povidone-iodine applications for
anterior segment intraocular surgery. Arch Ophthalmol 2005;
123: 161-5.
12. Trinavarat A, Atchaneeyasakul LO, Nopmaneejumruslers C,
Inson K. Reduction of endophthalmitis rate after cataract
surgery with preoperative 5% povidone-iodine. Dermatology
2006; 212(Suppl 1): S35-40.
13. Ta CN, Chang RT, Singh K, et al. Antibiotic resistance pat-
terns of ocular bacterial flora: a prospective study of patients
undergoing anterior segment surgery. Ophthalmology 2003;
110: 1946-51.
14. Park SH, Lim JA, Choi JS, Kim KA, Joo CK. The resistance
patterns of normal ocular bacterial flora to 4 fluoroquinolone
antibiotics. Cornea 2009; 28: 68-72.
15. Apt L, Isenberg S, Yoshimori R, Paez JH. Chemical prepa-
ration of the eye in ophthalmic surgery. III. Effect of po-vidone-iodine on the conjunctiva. Arch Ophthalmol 1984;
102: 728-9.
16. Ou JI, Ta CN. Endophthalmitis prophylaxis. Ophthalmol Clin
North Am 2006; 19: 449-56.
17. De Kaspar HM, Chang RT, Shriver EM, et al. Three-day ap-
plication of topical ofloxacin reduces the contamination rate
of microsurgical knives in cataract surgery: a prospective
randomized study. Ophthalmology 2004; 111: 1352-5.
18. Carothers TS, Coats DK, McCreery KM, et al. Quantification
of incidental needle and suture contamination during stra-
bismus surgery. Binocul Vis Strabismus Q 2003; 18: 75-9.
19. Olitsky SE, Vilardo M, Awner S, Reynolds JD. Needle sterility
during strabismus surgery. J AAPOS 1998; 2: 151-2.
Address for correspondence:
Dr. Martin M. Nentwich
Ludwig-Maximilians-UniversityDepartment of Ophthalmology
Klinikum der Universitt Mnchen
Campus Innenstadt
Mathildenstrasse 8
80336 Munich
Germany
ACKNOWLEDGEMENTS
Supported in part by Georg and Hannelore Zimmermann
Foundation, Germany.
The authors report no proprietary interest.
The data were presented in part at the 107th meeting of the German
Ophthalmological Society (DOG), Leipzig, Germany, September 24-
27, 2009.
REFERENCES
1. Lemley CA, Han DP. Endophthalmitis: a review of current
evaluation and management [erratum in 2007; 27: 7]. Retina
2007; 27: 662-80.
2. Taban M, Behrens A, Newcomb RL, et al. Acute endophthal-
mitis following cataract surgery: a systematic review of the
literature. Arch Ophthalmol 2005; 123: 613-20.3. Bannerman TL, Rhoden DL, McAllister SK, Miller JM, Wilson
LA. The source of coagulase-negative staphylococci in the
Endophthalmitis Vitrectomy Study. A comparison of eyelid
and intraocular isolates using pulsed-field gel electrophore-
sis. Arch Ophthalmol 1997; 115: 357-61.
4. Speaker MG, Milch FA, Shah MK, Eisner W, Kreiswirth BN.
Role of external bacterial flora in the pathogenesis of acute
postoperative endophthalmitis. Ophthalmology 1991; 98:
639-49; discussion 650.
5. Shockley RK, Jay WM, Fishman PH, Aziz MZ, Rissing JP. Ef-
fect of inoculum size on the induction of endophthalmitis in
aphakic rabbit eyes. Acta Ophthalmol 1985; 63: 35-8.
6. Speaker MG, Menikoff JA. Prophylaxis of endophthalmi-tis with topical povidone-iodine. Ophthalmology 1991; 98:
1769-75.
7. Binder C, de Kaspar HM, Engelbert M, Klauss V, Kampik A.
Bacterial colonization of conjunctiva with Propionibacterium
acnes before and after povidone iodine administration before
intraocular interventions. Ophthalmologe 1998; 95: 438-41.
8. Binder CA, Mio de Kaspar H, Klauss V, Kampik A. Preop-
erative infection prophylaxis with 1% povidone-iodine so-
lution based on the example of conjunctival staphylococci.
Ophthalmologe 1999; 96: 663-7.
9. Isenberg SJ, Apt L, Campeas D. Ocular applications of povi-
done-iodine. Dermatology 2002; 204(Suppl 1): S92-5.
10. Ta CN, Singh K, Egbert PR, de Kaspar HM. Prospective